Última Hora: "SEF abre concurso para admitir 100 inspetores - Diário de Notícias - Lisboa" Thu, 14 Dec 2017 15:04:00 GMT    "Anacom está analisar alterar condições do serviço postal - Jornal de Negócios - Portugal" Thu, 14 Dec 2017 18:29:00 GMT    "Raríssimas: Jerónimo de Sousa acredita que a "procissão ainda vai no adro" - Diário de Notícias - Lisboa" Thu, 14 Dec 2017 19:33:09 GMT    "Governo PS e os apoios à Raríssimas. Valor manteve-se, não quadruplicou - Observador" Thu, 14 Dec 2017 12:11:41 GMT    "BES: Tribunal declara nula acusação de BdP contra Salgado e Amílcar Pires - Público.pt" Thu, 14 Dec 2017 21:16:11 GMT   "This RSS feed URL is deprecated" Thu, 14 Dec 2017 21:19:39 GMT    "Estados Unidos aprovam fim da neutralidade da internet - RTP" Thu, 14 Dec 2017 20:31:00 GMT    "Novo modelo da Autoeuropa faz disparar produção automóvel em Portugal - Expresso" Thu, 14 Dec 2017 16:56:00 GMT    "Uber cobra 12 mil euros por viagem de 20 minutos - Dinheiro Vivo" Thu, 14 Dec 2017 18:18:43 GMT    "Nuno Mota Pinto vai presidir ao Montepio e os restantes administradores deverão sair com Félix Morgado - Expresso" Thu, 14 Dec 2017 20:28:00 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Mostrar Notícias:
 Ver notícias de outros activos

Pesquisa de notícias relativas à acção Sepracor Inc. (ordenadas pela data):

This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news


Minerva Neurosciences Names Richard Russell President
GlobeNewswire (press release)
He then served as President and Chief Executive Officer of Stallergenes Greer, Inc., the North American subsidiary of Stallergenes Greer, PLC. Previously, Mr. Russell was Executive Vice President and Chief Commercial Officer at Sunovion (formerly ...

e mais »

Difficult Defenses in the Courtroom: December 2017
Healio
Faculty members report the following financial relationships: Andrew A. Nierenberg, MD, has disclosed the following relevant financial relationships: Appliance Computing Inc. (Mindsite); Astra Zeneca; Brain Cells, Inc.; Brandeis University; Bristol ...


Global Asthma Medication Market Research:Opportunities by Regions, Types, Applications, Trend Forecast to 2022
MilTech
Global Asthma Medication industry 2012-2022 report shares information regarding key drivers, challenges and Opportunities with its impact by regions. Asthma Medication Market report provides Manufacturers, regional analysis, Segment by Type ...

e mais »

Zacks Small Cap Research (press release)

PULM: Business And Financial Update For Third Quarter 2017
Zacks Small Cap Research (press release)
On November 9, 2017 Pulmatrix (NASDAQ:PULM) announced their third quarter financial results and provided operational highlights. Revenue of $0.3 million was recorded for the quarter which was related to the grant received from the Cystic Fibrosis ...


Minerva Neurosciences, Inc. (NASDAQ:NERV) Files An 8-K Unregistered Sales of Equity Securities
Market Exclusive
Previously, Mr.Russell was executive vice president and chief commercial officer at Sunovion (formerly Sepracor), executive vice president, neurodegenerative diseases and rheumatology, US, for EMD Serono and vice president, marketing at Sanofi-Aventis ...


Kala Pharmaceuticals Appoints Todd Bazemore as Chief Operating Officer
Business Wire (press release)
... (USA), Inc. since September 2016, where he was instrumental in building the U.S. operations to support the company's regulatory and commercial strategy. Prior to joining Santhera U.S., Todd served as Executive Vice President and Chief Commercial ...

e mais »

TechnoPOW (blog)

Desloratadine Market Healthcare, Clinical Reviews, Survey Reports 2017 to 2022
TechnoPOW (blog)
Leading Manufacturers Analysis in Global Desloratadine Market 2017: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt. The Global Desloratadine ...

e mais »

Kala Pharmaceuticals Appoints Andrew I. Koven to Board of Directors
Business Wire (press release)
Prior to that , he held roles as Executive Vice President and Chief Administrative and Legal Officer at Inspire Pharmaceuticals Inc., where he oversaw all matters related to legal, quality and compliance, corporate development and licensing and ...

e mais »

Novelion Therapeutics Appoints Mark Corrigan, MD to Board of Directors
GlobeNewswire (press release)
Dr. Corrigan was previously president and chief executive officer of Zalicus Inc. Prior to that, he was executive vice president, research & development of Sepracor Inc. (now Sunovion Pharmaceuticals). Prior to joining Sepracor, Dr. Corrigan spent 10 ...

e mais »

Belgium's Ablynx enters the US market
PMLiVE
Ablynx Belgium biopharmaceutical company Ablynx has established a beachhead in the US, setting up a new subsidiary for that market. Ablynx, Inc will be led by newly-appointed general manager Daniel Schneider, who will be based on the east coast. One of ...

e mais »

Flex Pharma Reports Third Quarter 2017 Financial Results
Business Wire (press release)
Flex Pharma, Inc. (NASDAQ:FLKS), a clinical-stage biotechnology company that is developing innovative and proprietary treatments in Phase 2 randomized, controlled trials for cramps and spasticity associated with severe neurological diseases such as ...

e mais »

ZIOPHARM Appoints Amy Trevvett Vice President of Investor Relations and Corporate Communications
GlobeNewswire (press release)
... Relations and Corporate Communications at HeartWare International, Inc., a leading innovator of less-invasive, miniaturized circulatory support technologies for advanced heart failure, which was acquired by Medtronic plc. Prior to HeartWare, Ms ...

e mais »

Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development
Business Wire (press release)
?In partnership with CMO Tom Wessel, my former Sepracor colleague, we are poised to execute on our US Phase 2 development plans.? Tweet this. Flex Pharma, Inc. (NASDAQ: FLKS), focused on developing treatments for cramps and spasms associated with ...

e mais »

Sunovion Pharmaceuticals Inc. Announces Company Name Change
Business Wire (press release)
BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion), formerly Sepracor Inc. (Sepracor), announced today that it has formally changed its name. The change occurs on approximately the one year anniversary of the acquisition of Sepracor by Dainippon ...

e mais »

Frequency Therapeutics Announces its Board of Directors and the Appointment of Marc A. Cohen as Chairman
Yahoo Finance
The Board Members include Tim Barberich, founder and former CEO and Chairman of Sepracor, Inc. (now known as Sunovion), Marc Kozin, Senior Advisor and former President of L.E.K. Consulting, Robert S. Langer, Sc.D., Frequency Co-founder and the David H ...

e mais »

Dainippon Sumitomo Pharma to Acquire Sepracor for US $23.00 Per Share in an All-Cash Tender Offer Valued at ...
FierceBiotech
OSAKA, Japan & MARLBOROUGH, Mass.--(BUSINESS WIRE)--Dainippon Sumitomo Pharma Co., Ltd. ("DSP", TSE: 4506) and Sepracor Inc. ("Sepracor", Nasdaq: SEPR) today announced that they have entered into a definitive agreement pursuant to which DSP will ...
Drugmaker Sepracor Accepts $2.6B Buyout Offer from Japan's DainipponXconomy

todos os 485 artigos de notícias »

Rewire

Religious Imposition Proponents Find an Ally in the White House
Rewire
The firm's clients between those years included AstraZeneca Pharmaceuticals, Sepracor Inc, and the National Association of Spine Specialists. Another hire, Anna Pilato, is now serving as deputy assistant secretary for external affairs in the agency's ...


Sunovion Celebrates Five-Year Anniversary Milestone
Business Wire (press release)
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) announced today that it is celebrating its five-year anniversary. Sunovion was established in October 2010 following the integration of Sepracor Inc. and Dainippon Sumitomo ...

e mais »

TheChronicleHerald.ca

PEI's BioVectra buys former Sepracor plant in Windsor
TheChronicleHerald.ca
A Charlottetown drug manufacturer has acquired a mothballed Windsor pharmaceutical plant and plans to reopen the facility in early 2016. BioVectra Inc. purchased the former Sepracor Canada (Nova Scotia) Ltd. facility in May. The Sepracor operation ...

e mais »

Sunovion Pharmaceuticals to Acquire Cynapsus Therapeutics
Business Wire (press release)
MARLBOROUGH, Mass. & TORONTO--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) and Cynapsus Therapeutics Inc. (Cynapsus) (NASDAQ: CYNA) (TSX: CTH) today announced that the companies have signed a definitive agreement under which Sunovion will ...

e mais »

PR Newswire (press release)

Genzyme Corporation Pays $5.885 Million To Resolve False Claims Act Allegations; Judgment Involving Cases ...
PR Newswire (press release)
Those defendants include Allergan, Inc., Amgen, Inc., Bradley Pharmaceuticals, Inc., Eisai, Inc., Mallincrodt, Inc., Novo Nordisk, Inc., Reliant Pharmaceuticals, Inc., Sepracor, Inc., and Upsher-Smith Laboratories, Inc. The settlement with Genzyme ...

e mais »

Boston Globe

FDA approves Marlborough company's epilepsy drug
Boston Globe
An epilepsy tablet made by Marlborough-based Sunovion Pharmaceuticals Inc. won US approval Friday to be sold as a primary therapy for hundreds of thousands of Americans suffering from partial-onset seizures. The drug, called Aptiom, has been on the ...

e mais »

Acer Therapeutics Appoints Dr. William T. Andrews as Chief Medical Officer
GlobeNewswire (press release)
Previously, Dr. Andrews held senior leadership positions and positions of increasing responsibility at Aegerion Pharmaceuticals, Santhera Pharmaceuticals, Sepracor, and ClinQuest. He received his undergraduate degree in Biology from Harvard University ...

e mais »

Flex Pharma Names William McVicar President and Chief Executive Officer
Business Wire (press release)
Flex Pharma, Inc. (NASDAQ:FLKS), a clinical-stage biotechnology company that is developing innovative and proprietary treatments for cramps and spasticity associated with severe neurological diseases including multiple sclerosis (MS), Charcot-Marie ...

e mais »

CoLucid Pharmaceuticals Announces Election of Mark Corrigan, MD, to Board of Directors
GlobeNewswire (press release)
Dr. Corrigan serves as a director of EPIRUS Biopharmaceuticals, Inc., and Cardiome Pharma Corp. Previously, he served as president and chief executive officer of Zalicus, Inc., a predecessor of EPIRUS Biopharmaceuticals, from January 2010 until the two ...

e mais »

Allergy Treatment Market Global Industry Analysis, Trends and Forecast, 2016-2026
LANews By Abhishek Budholiya (press release) (blog)
An allergy is a heightened sensitivity of immune system. Allergy occurs when a foreign substance which is harmless in nature reacts with immune system. These foreign substances are called allergens. Some of the allergens that affect the immune system ...

e mais »

Sunovion Pharmaceuticals Canada Inc. Announces Company Name Change
Canada NewsWire (press release)
Sepracor Pharmaceuticals, Inc. changes name, maintains commitment to developing scientifically-advanced central nervous system, cardiovascular disease and infectious disease therapies that improve patients' lives. MISSISSAUGA, ON, Aug. 17, 2011 /CNW ...

e mais »

TheChronicleHerald.ca

Shutdown at Windsor drug plant will cost 32 jobs
TheChronicleHerald.ca
A Windsor pharmaceuticals plant will shut down in about six months, putting 32 people out of work. Sunovion Pharmaceuticals Inc. of Marlborough, Mass., said Wednesday its Sepracor Canada (Nova Scotia) Ltd. plant will cease operations near the middle of ...

e mais »

Kala Pharmaceuticals Appoints Mark Iwicki as Executive Chairman
Business Wire (press release)
Prior to joining Kala, Mr. Iwicki served as President and Chief Executive Officer of Civitas Therapeutics, Inc. (Civitas), which was acquired by Acorda Therapeutics, Inc. Prior to joining Civitas, Mr. Iwicki served as Chief Executive Officer of Blend ...

e mais »

Boston Globe

Sepracor joins ranks of growing Mass. firms
Boston Globe
Sepracor Inc., the Marlborough drug maker behind the Lunesta sleep aid, plans to nearly double the size of its headquarters, the latest in a wave of expansion by Massachusetts life sciences companies. Sepracor executives said the company will build a ...


Largura do Site:

 Imagem de Fundo:

Copyright@1998-2017 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters